Solid Biosciences is trading 13.3% up at $8.00 in pre-market on October 6, 2026, versus its October 5 close of $7.06, with no confirmed company-specific catalyst identified.
- The move follows the prior session’s 3.07% gain.
- The latest identified company announcement was October 1 inducement grants; the investor-relations release page shows no October 5 announcement.
- Major indices are only modestly higher pre-market, which does not clearly explain the move.